EGFR and neoplasm: Tumor-associated fibroblasts induce also the direct proliferation of keratinocytes, releasing a ligand of epidermal growth factor receptor (EGFR), namely heparin-binding EGF like growth factor (HBEGF), against which further studies may create monoclonal antibodies [8].